MedPath

Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population

Not Applicable
Completed
Conditions
Diabetic Retinopathy
Registration Number
NCT00799695
Lead Sponsor
Henry Ford Health System
Brief Summary

Diabetic retinopathy is the major cause of blindness in working age Americans, and screening for it is cost-effective. There are a quarter of a million people in Southeast Michigan with diabetes and pre-diabetes.

Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions.

This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations.

Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times.

Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
561
Inclusion Criteria
  • were Henry Ford Health System patients,
  • diabetic
  • using the BCBSM payer plan
Exclusion Criteria
  • retina examination in prior year

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
a change in the proportion of diabetic patients who acted as a result of the phone contact, and obtained a retina eye exam.3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath